Medicine
Disulfiram 250 mg tablet
Disulfiram 250 mg tablet is a generic prescription medicine for oral use, made by 5 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F).
Key facts
- Active ingredient (INN)
- Disulfiram
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 100 tablets and 4 more
- Manufacturers
- Chartwell RXGolden State Medical SupplyAlvogenBryant Ranch PrepackSigmapharm Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07BB01 Disulfiram
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 December 2012
- Identifiers
- RxCUI 197623, 197624DailyMed set ID b90f8ff4-4fb3-46ab-8149-cb55f24a4044, d3832a1a-a140-49c1-a7df-134fa81341e3, 40f5497f-fe84-43b2-8ff4-32d59edf3917 +2NDC 47781-607, 60429-196, 42794-028 +2Application ANDA091681, ANDA091619, ANDA091563
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle, plastic | 47781-607-30 | Alvogen | 9 August 2013 |
| 30 tablet in 1 bottle | 62135-431-30 | Chartwell RX | 2 November 2021 |
| 90 tablet in 1 bottle | 62135-431-90 | Chartwell RX | 2 November 2021 |
| 30 tablet in 1 bottle | 42794-028-08 | Sigmapharm Laboratories | 1 November 2021 |
| 90 tablet in 1 bottle | 63629-5466-1 | Bryant Ranch Prepack | 7 April 2025 |
| 100 tablet in 1 bottle | 60429-196-01 | Golden State Medical Supply | 13 November 2013 |
| 30 tablet in 1 bottle, plastic | 60429-196-30 | Golden State Medical Supply | 13 November 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 28 August 1951 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Disulfiram
Clinical summary
Disulfiram is an aldehyde dehydrogenase inhibitor. It is available as tablets for oral use. MedsAcross supplies Disulfiram for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DisulfiramFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Disulfiram prescribing information (Alvogen) · U.S. National Library of Medicine, DailyMed
Need Disulfiram 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.